Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))

Amit Bar-Or; Peter A.J. Calabresi; Douglas Arnold; Clyde Markowitz; Stuart Shafer; Lloyd H. Kasper; Emmanuelle Waubant; Suzanne Gazda; Robert J. Fox; Michael Panzara; Neena Sarkar; Sunil Agarwal; Craig H. Smith

doi:10.1002/ana.21441

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))

Amit Bar-Or, Peter A.J. Calabresi, Douglas Arnold, Clyde Markowitz, Stuart Shafer, Lloyd H. Kasper, Emmanuelle Waubant, Suzanne Gazda, Robert J. Fox, Michael Panzara, Neena Sarkar, Sunil Agarwal, Craig H. Smith

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	803
Number of pages	1
Journal	Annals of neurology
Volume	63
Issue number	6
DOIs	https://doi.org/10.1002/ana.21441
State	Published - Jun 2008

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1002/ana.21441

Cite this

Bar-Or, A., Calabresi, P. A. J., Arnold, D., Markowitz, C., Shafer, S., Kasper, L. H., Waubant, E., Gazda, S., Fox, R. J., Panzara, M., Sarkar, N., Agarwal, S., & Smith, C. H. (2008). Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495)). Annals of neurology, 63(6), 803. https://doi.org/10.1002/ana.21441

@article{70dbc201a6574531a70455fee839739e,

title = "Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))",

author = "Amit Bar-Or and Calabresi, {Peter A.J.} and Douglas Arnold and Clyde Markowitz and Stuart Shafer and Kasper, {Lloyd H.} and Emmanuelle Waubant and Suzanne Gazda and Fox, {Robert J.} and Michael Panzara and Neena Sarkar and Sunil Agarwal and Smith, {Craig H.}",

year = "2008",

month = jun,

doi = "10.1002/ana.21441",

language = "English (US)",

volume = "63",

pages = "803",

journal = "Annals of neurology",

issn = "0364-5134",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - Rituximab in relapsing-remitting multiple sclerosis

T2 - A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))

AU - Bar-Or, Amit

AU - Calabresi, Peter A.J.

AU - Arnold, Douglas

AU - Markowitz, Clyde

AU - Shafer, Stuart

AU - Kasper, Lloyd H.

AU - Waubant, Emmanuelle

AU - Gazda, Suzanne

AU - Fox, Robert J.

AU - Panzara, Michael

AU - Sarkar, Neena

AU - Agarwal, Sunil

AU - Smith, Craig H.

PY - 2008/6

Y1 - 2008/6

UR - http://www.scopus.com/inward/record.url?scp=46749140939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749140939&partnerID=8YFLogxK

U2 - 10.1002/ana.21441

DO - 10.1002/ana.21441

M3 - Comment/debate

AN - SCOPUS:46749140939

SN - 0364-5134

VL - 63

SP - 803

JO - Annals of neurology

JF - Annals of neurology

IS - 6

ER -

Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this